{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:14:52Z","timestamp":1793672092208,"version":"4.5.1"},"reference-count":29,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2023,2,24]]},"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1136\/ejhpharm-2022-003672","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T09:55:12Z","timestamp":1678960512000},"page":"440-446","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacokinetic\/pharmacodynamic analysis of vancomycin in patients with<i>Enterococcus faecium<\/i>bacteraemia: a retrospective cohort study"],"prefix":"10.1136","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8782-1674","authenticated-orcid":false,"given":"Naohiro","family":"Tochikura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So","family":"Iwabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Aso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakae","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Ootsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Ooba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"2024123003351196000_31.5.440.1","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2016.174"},{"key":"2024123003351196000_31.5.440.2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2334-14-92","article-title":"Treatment of gram-positive infections in critically ill patients","volume":"14","author":"Vazquez-Guillamet","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2024123003351196000_31.5.440.3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.medmal.2020.01.001","article-title":"Comparative review of imipenem\/cilastatin versus meropenem","volume":"50","author":"Salmon-Rousseau","year":"2020","journal-title":"Med Mal Infect"},{"key":"2024123003351196000_31.5.440.4","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02188-15","article-title":"Involvement of the eukaryote-like kinase-phosphatase system and a protein that interacts with penicillin-binding protein 5 in emergence of cephalosporin resistance in cephalosporin-sensitive class A penicillin-binding protein mutants in Enterococcus faecium","volume":"7","author":"Desbonnet","year":"2016","journal-title":"MBio"},{"key":"2024123003351196000_31.5.440.5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu398"},{"key":"2024123003351196000_31.5.440.6","doi-asserted-by":"crossref","unstructured":"Tsutsuura M , Moriyama H , Kojima N , et al . The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing. BMC Infect Dis 2021;21. doi:10.1186\/s12879-021-05858-6","DOI":"10.1186\/s12879-021-05858-6"},{"key":"2024123003351196000_31.5.440.7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa303"},{"key":"2024123003351196000_31.5.440.8","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030489","article-title":"Clinical practice guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring","volume":"14","author":"Matsumoto","year":"2022","journal-title":"Pharmaceutics"},{"key":"2024123003351196000_31.5.440.9","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01602-17","article-title":"Pharmacokinetic\/pharmacodynamic determinants of vancomycin efficacy in enterococcal bacteremia","volume":"62","author":"Jumah","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2024123003351196000_31.5.440.10","doi-asserted-by":"crossref","unstructured":"Nakakura I , Sakakura K , Imanishi K , et al . Association between vancomycin pharmacokinetic\/pharmacodynamic parameters, patient characteristics, and mortality in patients with bacteremia caused by vancomycin-susceptible Enterococcus faecium: a single-center retrospective study. J Pharm Health Care Sci 2019;5. doi:10.1186\/s40780-019-0138-2","DOI":"10.1186\/s40780-019-0138-2"},{"key":"2024123003351196000_31.5.440.11","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq433"},{"key":"2024123003351196000_31.5.440.12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-1-200401060-00008"},{"key":"2024123003351196000_31.5.440.13","doi-asserted-by":"publisher","DOI":"10.1159\/000339789"},{"key":"2024123003351196000_31.5.440.14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s11095-021-03030-y","article-title":"Performance of area under the concentration-time curve estimations of vancomycin with limited sampling by a newly developed web application","volume":"38","author":"Oda","year":"2021","journal-title":"Pharm Res"},{"key":"2024123003351196000_31.5.440.15","doi-asserted-by":"crossref","unstructured":"Sohn Y , Rim JH , Cho Y , et al . Association of vancomycin trough concentration on the treatment outcome of patients with bacteremia caused by Enterococcus species. BMC Infect Dis 2021;21. doi:10.1186\/s12879-021-06809-x","DOI":"10.1186\/s12879-021-06809-x"},{"key":"2024123003351196000_31.5.440.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074734","article-title":"Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes","volume":"8","author":"Gudiol","year":"2013","journal-title":"PLoS One"},{"key":"2024123003351196000_31.5.440.17","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12236"},{"key":"2024123003351196000_31.5.440.18","doi-asserted-by":"crossref","unstructured":"Zhang Y , Du M , Chang Y , et al . Incidence, clinical characteristics, and outcomes of nosocomial Enterococcus spp. bloodstream infections in a tertiary-care hospital in Beijing, China: a four-year retrospective study. Antimicrob Resist Infect Control 2017;6. doi:10.1186\/s13756-017-0231-y","DOI":"10.1186\/s13756-017-0231-y"},{"key":"2024123003351196000_31.5.440.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2016.02.017"},{"key":"2024123003351196000_31.5.440.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2007.12.012"},{"key":"2024123003351196000_31.5.440.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.10.003"},{"key":"2024123003351196000_31.5.440.22","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku379"},{"key":"2024123003351196000_31.5.440.23","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph110303424"},{"key":"2024123003351196000_31.5.440.24","unstructured":"Clinical and Laboratory Standards Institute (CLSI) . Performance standards for antimicrobial susceptibility testing: 32nd informational supplement M100-S32. 2022. Available: em100.edaptivedocs.net\/GetDoc.aspx?doc=CLSI%20M100%20ED32:2022&sbssok=CLSI%20M100%20ED32:2022%20TABLE%202D&format=HTML&hl=enterococcus [Accessed 31 May 2022]."},{"key":"2024123003351196000_31.5.440.25","unstructured":"EUCAST . Breakpoint tables for interpretation of MICs and zone diameters. Version 12.0. 2022. Available: www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_12.0_Breakpoint_Tables.pdf [Accessed 31 May 2022]."},{"key":"2024123003351196000_31.5.440.26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/1120009X.2018.1516272","article-title":"Distribution of main gram-positive pathogens causing bloodstream infections in United States and European hospitals during the SENTRY Antimicrobial Surveillance Program (2010-2016): concomitant analysis of oritavancin in vitro activity","volume":"30","author":"Mendes","year":"2018","journal-title":"J Chemother"},{"key":"2024123003351196000_31.5.440.27","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00210-06"},{"key":"2024123003351196000_31.5.440.28","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/ajhp\/zxac094","article-title":"Evaluation of pharmacist time dedicated to vancomycin dosing in adult patients using a 24-hour AUC nomogram or trough monitoring approach: a time motion study","volume":"79","author":"Chung","year":"2022","journal-title":"Am J Health Syst Pharm"},{"key":"2024123003351196000_31.5.440.29","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/ajhp\/zxab457","article-title":"The relationship of vancomycin 24-hour AUC and trough concentration","volume":"79","author":"Nix","year":"2022","journal-title":"Am J Health Syst Pharm"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2022-003672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T11:35:54Z","timestamp":1735558554000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2022-003672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,8,22]]},"published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1136\/ejhpharm-2022-003672"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2022-003672","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]}}}